Department of Hematology and Oncology, Charité Campus Benjamin Franklin, Berlin.
Third Department of Internal Medicine, University Medical Centre Mannheim, University of Heidelberg, Heidelberg.
Ann Oncol. 2011 May;22(5):1019-1029. doi: 10.1093/annonc/mdq442. Epub 2010 Nov 1.
Sepsis is a leading cause of mortality in neutropenic cancer patients. Early initiation of effective causative therapy as well as intensive adjunctive therapy is mandatory to improve outcome. We give recommendations for the management of adults with neutropenia and sepsis. The guidelines are written for clinicians involved in care of cancer patients and focus on pathophysiology, diagnosis and treatment of sepsis during neutropenia.
败血症是中性粒细胞减少症癌症患者死亡的主要原因。为了改善预后,必须尽早开始有效的病因治疗和强化辅助治疗。我们就中性粒细胞减少症和败血症患者的管理提出建议。本指南面向参与癌症患者治疗的临床医生,重点介绍中性粒细胞减少症期间败血症的病理生理学、诊断和治疗。